Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Inflation Is Giving This Dividend Growth Stock a Boost
Inflation Is Giving This Dividend Growth Stock a Boost

Brookfield Infrastructure (NYSE: BIPC)(NYSE: BIP) recently reported its fourth-quarter results. One of the recurring themes from that report was the positive effect it's seeing from inflation. That

Discover Earns a Perfect Score for LGBTQ+ Equality Nine Years in a Row
Discover Earns a Perfect Score for LGBTQ+ Equality Nine Years in a Row


For the ninth consecutive year, Discover has earned a perfect 100 score and been named a Best Place to Work for LGBTQ+ Equality by the Human Rights Campaign’s Annual Corporate Equality Index, a

If You Invested $10,000 in ASML in 2010, This Is How Much You Would Have Today
If You Invested $10,000 in ASML in 2010, This Is How Much You Would Have Today

ASML Holding (NASDAQ: ASML) is the world's only manufacturer of extreme ultraviolet (EUV) lithography systems. The semiconductor market's most advanced chip foundries -- including Taiwan

Market Analysts Are Urging Investors to Sell Stocks With No Earnings -- Should You Listen?
Market Analysts Are Urging Investors to Sell Stocks With No Earnings -- Should You Listen?

Stocks woke up on the wrong side of the bed to start 2022. The S&P 500 briefly flirted with "correction" territory (a drop of at least 10% from all-time highs), and the Nasdaq is down even more as

2 Growth Stocks That Could Turn $200,000 Into $1 Million in 10 Years
2 Growth Stocks That Could Turn $200,000 Into $1 Million in 10 Years

It's time in the market -- not timing the market -- that leads to life-changing wealth. Stocks may rise or fall on any given day for any number of reasons, but it's impossible to predict those

This Blue Chip Stock Upped Its Dividend: Should You Buy It?
This Blue Chip Stock Upped Its Dividend: Should You Buy It?

When the asset manager BlackRock (NYSE: BLK) reported fourth-quarter revenue and earnings in mid-January, the company also announced a large 18.2% increase in its quarterly dividend from $4.13 to

3 Lessons From Last Week's Wild Stock Market Ride
3 Lessons From Last Week's Wild Stock Market Ride

Last week was not an easy one for investors to stomach. After many months of relative stability, stocks finally plunged into correction territory. While things seem to have settled down this week

2 Top Cryptocurrencies to Buy and Hold in 2022 (and Beyond)
2 Top Cryptocurrencies to Buy and Hold in 2022 (and Beyond)

Currently, the crypto market is worth a collective $1.7 trillion. While impressive, that figure is actually down 43% from its high of $3 trillion in November 2021. In other words, the market has

My Take: 4 Strong Growth Stocks to Buy This Week
My Take: 4 Strong Growth Stocks to Buy This Week

Rising inflation and the threat of higher interest rates have crushed many of the market's favorite growth stocks over the past few months. That sell-off wasn't surprising, but plenty of babies were

3 Must-Know Tax Rules to Protect Your Money From Capital Gains
3 Must-Know Tax Rules to Protect Your Money From Capital Gains

One thing that separates regular income and investment income is how the IRS views them when it comes to taxes. Knowing the differences between the two can not only save you from a surprise tax

Here's What to Like About Johnson & Johnson's Q4 Update
Here's What to Like About Johnson & Johnson's Q4 Update

Healthcare giant Johnson & Johnson (NYSE: JNJ) reported its fourth-quarter results on Jan. 25, 2022. In this Motley Fool Live video, recorded on Jan. 26, Fool contributors Keith Speights and Brian

Merck Coughs Up a Failure With Its "Pipeline in a Product"
Merck Coughs Up a Failure With Its "Pipeline in a Product"

Merck (NYSE: MRK) has high hopes for gefapixant, an experimental drug that it's referred to as a "pipeline in a product." However, the U.S. Food and Drug Administration (FDA) recently poured some

Is It Too Late to Buy Microsoft?
Is It Too Late to Buy Microsoft?

With the recent sell-off in technology stocks, some investors may be looking at the large-cap tech giants for their portfolio. However, these tech giants have been the big outperformers over the

Why Jack Dorsey's Opinion on Bitcoin Scares Me
Why Jack Dorsey's Opinion on Bitcoin Scares Me

Block (NYSE: SQ) Chief Executive Officer Jack Dorsey is a Bitcoin (CRYPTO: BTC) extremist. I know extremist is kind of a charged word. I don't necessarily mean it in a negative way. Many people are

RH Is a Wonderful Business at a Great Price
RH Is a Wonderful Business at a Great Price

Warren Buffett has spoken of the advantages of buying a wonderful company at a fair price, instead of a fair company at a wonderful price. And the recent market sell-off has gone one step further

How Concerning Is Pfizer and Opko's Latest FDA Rejection?
How Concerning Is Pfizer and Opko's Latest FDA Rejection?

The U.S. Food and Drug Administration (FDA) recently refused to approve Pfizer's (NYSE: PFE) and Opko Health's (NASDAQ: OPK) growth hormone therapy, somatrogon. In this Motley Fool Live video

Better Buy: BlackBerry vs. Apple
Better Buy: BlackBerry vs. Apple

Back in 2010, BlackBerry (NYSE: BB) accounted for 43% of the smartphone platform market, according to Comscore. But over the following decade, it lost the entire market to Apple's (NASDAQ: AAPL)

Here's My Top Cryptocurrency to Buy in February
Here's My Top Cryptocurrency to Buy in February

It has been a difficult past few months for cryptocurrencies, as most of the major names have plunged from November highs. The crypto market as a whole has gone from about $3 trillion to its current

Are Beaten-Down Dividend Stocks a Bargain or a Trap?
Are Beaten-Down Dividend Stocks a Bargain or a Trap?

The stock market has been under pressure lately, and many of investors' favorite dividend stocks have fallen significantly from the highs, pushing yields higher in the process. In this Fool Live

Can Intel Catch Up to Taiwan Semiconductor by 2025?
Can Intel Catch Up to Taiwan Semiconductor by 2025?

In this segment of "Semiconductor Revolution" on Motley Fool Live, recorded on Jan. 20, Fool contributor Will Healy discusses Intel's (NASDAQ: INTC) ambitious plans to compete with TSMC (NYSE: TSM)

Should Investors Expect Aurora Cannabis to Post a Profit in Q2?
Should Investors Expect Aurora Cannabis to Post a Profit in Q2?

Cannabis company Aurora Cannabis (NASDAQ: ACB) reports its fiscal second-quarter earnings this month. The business has been working on improving its bottom line and while there has been progress in

Shifting Toward Bonds as Retirement Nears? 3 Mistakes to Avoid
Shifting Toward Bonds as Retirement Nears? 3 Mistakes to Avoid

There's a reason workers are often advised to load up on stocks in the course of saving for retirement. If you want to grow your IRA or 401(k) through the years, stocks are a good bet because

5 Charts That Show Roblox's Metaverse Success Is Very Real
5 Charts That Show Roblox's Metaverse Success Is Very Real

There is a lot of talk these days about the metaverse -- a term that has been defined in several ways. In general, though, it references a persistent digital space where users can be immersed in a

Brinker International (EAT) Q2 2022 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg
Brinker International (EAT) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool.

Brinker International (NYSE: EAT)Q2 2022 Earnings CallFeb 02, 2022, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

2 Stocks to Grab Now That the S&P 500 Is In Correction Territory
2 Stocks to Grab Now That the S&P 500 Is In Correction Territory

When a stock or index falls 10% from its all-time high, it is said to be in correction territory. While this isn't as scary-sounding as a bear market -- denoted by a 20% fall -- it should give